key: cord-0778982-2ds228gy
authors: Barman, Hasan Ali; Atici, M.D. Adem; Alici, M.D. Gokhan; Sit, M.D. Omer; Tugrul, M.D. Sevil; Gungor, M.D. Baris; Okuyan, M.D. Ertugrul; Sahin, M.D. Irfan
title: The effect of the severity COVID-19 infection on electrocardiography
date: 2020-10-07
journal: Am J Emerg Med
DOI: 10.1016/j.ajem.2020.10.005
sha: e49bff64b3cb03d8be5c8d03d6b187323181147c
doc_id: 778982
cord_uid: 2ds228gy

OBJECTIVE: Acute myocardial damage is detected in a significant portion of patients with coronavirus 2019 disease (COVID-19) infection, with a reported prevalence of 7–28%. The aim of this study was to investigate the relationship between electrocardiographic findings and the indicators of the severity of COVID-19 detected on electrocardiography (ECG). METHODS: A total of 219 patients that were hospitalized due to COVID-19 between April 15 and May 5, 2020 were enrolled in this study. Patients were divided into two groups according to the severity of COVID-19 infection: severe (n = 95) and non-severe (n = 124). ECG findings at the time of admission were recorded for each patient. Clinical characteristics and laboratory findings were retrieved from electronic medical records. RESULTS: Mean age was 65.2 ± 13.8 years in the severe group and was 57.9 ± 16.0 years in the non-severe group. ST depression (28% vs. 14%), T-wave inversion (29% vs. 16%), ST-T changes (36% vs. 21%), and the presence of fragmented QRS (fQRS) (17% vs. 7%) were more frequent in the severe group compared to the non-severe group. Multivariate analysis revealed that hypertension (odds ratio [OR]: 2.42, 95% confidence interval [CI]:1.03–5.67; p = 0.041), the severity of COVID-19 infection (OR: 1.87, 95% CI: 1.09–2.65; p = 0.026), presence of cardiac injury (OR: 3.32, 95% CI: 1.45–7.60; p = 0.004), and d-dimer (OR: 3.60, 95% CI: 1.29–10.06; p = 0.014) were independent predictors of ST-T changes on ECG. CONCLUSION: ST depression, T-wave inversion, ST-T changes, and the presence of fQRS on admission ECG are closely associated with the severity of COVID-19 infection.

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a disease with high mortality that was named coronavirus disease 2019 (COVID-19) and declared as a global pandemic by the World Health Organization (WHO). The COVID-19 infection may trigger acute cardiovascular events in patients with stable disease or may present with other cardiac complaints including acute coronary syndrome, myocarditis, myopericarditis, acute heart failure, arrhythmia, and sudden cardiac death ((1, 2), [3] [4] [5] . Cardiac Hydroxychloroquine and azithromycin are widely used in the treatment and prophylaxis of COVID-19 (6) . Both drugs are known to cause QT interval prolongation and a higher risk of J o u r n a l P r e -p r o o f torsades des pointes (7, 8) . Similarly, lopinavir/ritonavir may lead to QT and PR prolongation. In the case of myocardial injury or acute coronary syndrome that may develop during the follow-up of patients diagnosed with COVID-19, it is important to know the QRS-T morphology in the basal ECG. Therefore, basal ECG taken at the first admission is an important tool for such patients (9) . In addition, the predictors of worse prognosis on ECG in this group of patients have not yet been described. The aim of this study was to investigate baseline ECG parameters and indicators of severity and poor prognosis on ECG in COVID-19 patients.

The study included 219 patients with COVID-19 who underwent ECG at the time of admission between April 10 and 25, 2020 and were found to be positive for COVID-19 on real-time reverse-transcription polymerase chain reaction (RT-PCR) assay. Patients were divided into two groups according to the severity of COVID-19 infection: severe (n=95) and non-severe (n=124). Patients with a history of CAD, cardiomyopathy, heart failure, and severe valve disease were excluded from the study. Demographic characteristics including gender, age, smoking, known hyperlipidemia (HLD), hypertension (HT), and diabetes mellitus (DM) were retrieved from medical records. Laboratory parameters including urea, creatinine, sodium, potassium, glucose, hs-TnI, d-dimer, CK-MB, hemoglobin, white blood cell (WBC) count, procalcitonin, and C-reactive protein (CRP) were analyzed from the blood samples taken at the first admission. All patients were above 18 years of age and able to provide a written informed consent, which was a prerequisite for enrollment. The study complies with the Declaration of Helsinki and the trial protocol was approved by the local ethics committee and the Ministry of Health.

A 12-lead admission ECG was obtained from each patient before any treatment was started.

All standard 12-lead electrocardiograms were recorded on digitized 12- lead V5 was selected in all ECG recordings for the measurement of QRS duration, the QRS interval >120 ms was accepted as prolongation, corrected QT interval (QTc); the QT interval measured in either lead II or V5-6, QTc was calculated using Bazett"s formula (QTc = QT / (√RR) (11) . Right bundle branch block (RBBB) was defined as broad QRS > 120 ms, RSR" V1-V4 in the anterior ECG, DI, AVL, V5 and V6 in the lateral ECG, DII, DIII and aVF in the inferior ECG. QRS fragmentation (fQRS) was defined as a notch in the R wave or S wave in two consecutive leads associated with the myocardial region, or multiple R' waves and QRS<120 ms (12) .

According to the WHO interim guidance, the definitive diagnosis of COVID-19 is based on real-time RT-PCR test. In our patients, SARS-CoV-2 RNA was detected by real-time RT-PCR method that was conducted in the Public Health Microbiology Reference Laboratory of the Ministry of Health.

Severe disease was defined in the presence of any of the following criteria: (1) respiratory distress (respiratory rate ≥30 breaths per min), (2) oxygen saturation at rest ≤93%, (3) the ratio of partial pressure of arterial oxygen (PaO2) to fractional concentration of oxygen in the inspired air (FiO2) (Pao2:FiO2, ≤300 mmHg), or (4) critical complications (respiratory failure and requirement of mechanical ventilation, septic shock, and/or multiple organ dysfunction/failure and requirement of intensive care unit [ICU] admission) (13) . Acute cardiac injury was defined as serum hs-TnI levels above the 99 th percentile upper reference limit (14) .

All statistical tests were conducted using SPSS for Windows version 19.0 (SPSS Inc., Chicago, IL, USA). Normal distribution of data was assessed using Kolmogorov-Smirnov test. Continuous variables were expressed as mean ± standard deviation (SD) and categorical variables were expressed as percentages (%). Differences in categorical variables were compared between groups using Fisher"s Exact test and/or Chi-square test as needed.

Unpaired samples were compared using Student"s t-test or Mann Whitney U test as needed.

Independent variables of ST-T change and ICU admission were determined using univariate and multivariate logistic regression analyses. After performing univariate analysis, statistically significant variables were selected into the multivariate logistic regression analysis using the stepwise method. The results of univariate and multivariate regression analyses were presented as odds ratio (OR) with 95% confidence interval (CI). Significance was assumed at a two-sided p value of <0.05. Table 1 presents the demographic, clinical, and laboratory parameters of the 219 COVID-19 patients included in the study. No significant difference was found between the severe and non-severe groups in terms of gender while the mean age was significantly higher in the severe group compared to the non-severe group. Of all patients, male patients constituted 64%

(61/95) of the severe group and 56% (69/124) of the non-severe group. Mean age was 65.2 ± 13.8 years in the severe group as opposed to 57.9 ± 16.0 years in the non-severe group and a significant difference was established (p=0.001). However, no significant difference was found between the two groups with regard to body mass index (BMI), HT, DM, and HLD.

Hemoglobin, WBC, creatinine, sodium, glucose, CRP, procalcitonin, hs-TnI, D-dimer, and CK-MB values were significantly different in the two groups (p<0.05). Mortality rates were higher in the severe group compared to the non-severe group (52% vs 7%). Table 2 presents the comparison of ECG findings between the two groups. The PR interval and QRS duration values were within normal ranges while the heart rate (HR) and QTc Patients were also divided into two groups according to the presence of myocardial injury.

Myocardial injury was detected in 63 patients and their ECG features were shown in Table 3 Predictors of ICU admission were also analyzed by logistic regression analysis ( 

The present study investigated the effect of the severity of COVID-19 infection on the ECG parameters measured at admission and the main findings of the study are as follows: i) ST-T changes were the most prevalent ECG abnormality in the severe group, ii) ST depression, Twave inversion, ST-T changes, and presence of fQRS were more common in the severe group compared to the non-severe group, iii) presence of HT, severe clinical status, myocardial injury and d-dimer elevation were found to be independent predictors of ST-T changes, and iv) age, d-dimer, procalcitonin, myocardial injury, ST depression and presence of fQRS were found to be independent predictors of ICU admission .

Coronavirus disease 2019 (COVID-19) is a pandemic that has affected more than 20 million patients worldwide to date. In many studies, an increased level of troponin, which is a sign of cardiac involvement, has been detected in a significant portion of patients and it has been shown that troponin levels are associated with the severity of the disease and mortality (5, 15, 16) . Cardiac injury can be measured via biomarkers (such as troponin) under laboratory conditions while it cannot be assessed by invasive procedures (such as biopsy) that can explain the pathophysiology of cardiac involvement due to the risk of infection. Therefore, the use of non-invasive procedures in evaluating cardiac involvement is of paramount importance.

Electrocardiography (ECG) is a commonly used noninvasive test providing rapid results in the evaluation of the cardiovascular system. ECG is an important diagnostic tool used in the assessment of cardiac arrhythmias and myocardial ischemia. Basal ECG is routinely performed before treatment due to the agents used in the treatment of COVID-19 patients. In a study involving 393 patients with COVID-19, atrial arrhythmias were found more frequently in patients requiring mechanical ventilation (17.7% vs. 1.9%) (17) . In Italy, a 60% increase in the rate of out-of-hospital sudden cardiac death was shown during the 2020 COVID-19 pandemic period compared to the same time period of the year 2019 (18) . In a study involving 138 patients that were followed due to COVID-19-related pneumonia in Wuhan, arrhythmias were detected in 17% of all patients and in 44% of the patients J o u r n a l P r e -p r o o f hospitalized in ICU (19) . In another study that involved 187 COVID-19 patients, 11% of patients had ventricular tachyarrhythmias at admission (20) . Sinus tachycardia is the most common arrhythmia in COVID-19 patients. In Italy, in a patient who was urgently taken to the catheterization laboratory due to a chest pain and electrocardiographic changes, the patient was diagnosed with COVID-19 while no obstructive CAD was detected (21). In a case report evaluating the ECGs of two patients with multiple comorbidities, one patient's serial ECG measurements indicated sinus rhythm with first-degree AVB, sinus tachycardia, first-degree AVB with SITIIIQIII, Mobitz type 1 second-degree AVB and atrioventricular junctional escape beat, high-grade AVB or nearly complete AVB with junctional escape rhythm, firstdegree AVB, and recovery of SITIIIQIII. In the second patient, serial ECG measurements In our study, electrical conduction studies indicated RBBB in 5%, IVCD in 5%, and fQRS in 12% of the patients. Fragmented QRS (fQRS) has been identified as a predictor of cardiac events in various disorders, reflecting nonspecific myocardial depolarization. Moreover, fQRS is an electrocardiographic marker of myocardial fibrosis. The prognostic significance of fQRS has mainly been studied in patients with myocardial infarction (MI), ischemic and nonischemic cardiomyopathies, arrhythmogenic right ventricular dysplasia, and hypertrophic cardiomyopathies (24, 25) . In our study, fQRS was found more frequently in the severe group than in the non-severe group, particularly in inferior leads. Similarly, the presence of fQRS was observed more frequently in patients with myocardial injury compared to patients without myocardial injury. The PR interval reflects conduction through the AV node. In our study, PR> 200 ms (first-degree AVB) was observed in 5 (2%) and PR <120 ms (short PR interval) was detected in 10 (4%) patients.

The QT interval represents the time taken for ventricular depolarization and repolarization.

An abnormally prolonged QT (>500 ms) is associated with an increased risk of ventricular J o u r n a l P r e -p r o o f arrhythmias, particularly torsades de pointes. In a previous multicentric study, 260 (6.1%) out of 4,250 patients were diagnosed with COVID-19 and had QTc >500 ms at admission (26) .

However, in another study involving 84 patients taking hydroxychloroquine and azithromycin, baseline QTc was measured as 435 ms before taking these drugs (17) .

Advanced age, female gender, diuretic use, hypokalemia, hypomagnesemia, fever, long basal QTc distance (>450 ms), heart failure, ischemia and sepsis, and medications used in treatment are among the risk factors for prolonged QTc interval (27) . In our study, no significant difference was found between the severe and non-severe groups with regard to baseline QTc measurements, whereas QTc >500 was observed more frequently in the severe patients with myocardial injury.

The ST segment represents the interval between ventricular depolarization and repolarization.

Myocardial ischemia or infarction is the most important cause of ST segment abnormality (elevation or depression). ST depression due to subendocardial ischemia may be present in a variable number of leads and with variable morphology. It is often most prominent in the left precordial leads V4-6 plus leads I, II and aVL. The prevalence of ST-T changes in the resting ECG in the Framingham study was found to be 8.5% in men and 7.7% in women and it was reported that the CAD-related morbidity and mortality increased twice in these cases (28) .

Myocardial ischemia affects especially the repolarization phase due to intracellular low K + ion, during which action potential times are shortened and the repolarization pattern changes Therefore, basal ECG taken at the first admission to hospital is an important tool for these patients (9) . Moreover, basal ECG will provide an evaluation of the ST-T wave in the case of ACS, which may develop during the follow-up of the patient. In addition, the use of chloroquine and azithromycin in the treatment of COVID-19 may cause prolongation in QTc, thereby facilitating the diagnosis of existing channelopathy (such as Brugada and long QT syndrome) along with the measurement of basal QTc interval.

The present study is of high value in that it showed the relationship between ECG measurements obtained at the time of admission and the severity of the disease and cardiac injury in patients diagnosed with COVID-19. The ST depression detected in ECG is a marker of cardiac injury and can be used as an indicator of prognosis in these patients. The COVID-19 patients detected with ischemic (ST-T changes) and arrhythmic parameters (fQRS, QTc prolongation) on basal ECG should be monitored for sudden death risk. In our study, predictors of arrhythmia (e.g. fQRS) and repolarization changes (e.g. ST-T changes) were found to be the independent predictors of cardiac involvement in COVID-19 patients.

In conclusion, ECG findings (ST-T changes, fQRS) are closely associated with the severity of COVID-19. Our study demonstrated that the ECG findings at admission could be used for predicting the presence or absence of myocardial involvement and disease severity. It was J o u r n a l P r e -p r o o f also found that cardiac involvement is higher in patients with ST-T changes and fQRS, which may lead to a worse prognosis in such patients.

Our study had several limitations. First and foremost, it was a single-center study and had a relatively small patient population. Second, no previous ECG recordings of the patients (during their healthy status) were available. Third, no echocardiographic findings were obtained due to the risk of infection transmission. J o u r n a l P r e -p r o o f 

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People"s Hospital. Intensive care medicine

Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)

Coronavirus disease 2019 (COVID-19) and cardiovascular disease

Mild or Moderate Covid-19

Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia

Risk evaluation of Azithromycin-Induced QT prolongation in real-world practice

COVID-19 infection unmasking Brugada syndrome. HeartRhythm Case Reports. 2020. 10. Prineas RJ, Crow RS, Zhang Z-M. The Minnesota code manual of electrocardiographic findings

A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs

Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease

First case of 2019 novel coronavirus in the United States

Fourth universal definition of myocardial infarction

Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China

Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Progress in cardiovascular diseases

The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin

Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)

Cardiovascular disease, drug therapy, and mortality in Covid-19

Clinical characteristics of Covid-19 in New York city

Characteristic ECG manifestations in patients with COVID-19

ECG changes after rabbit coronavirus infection

Prognostic Value of QRS Fragmentation in Patients with Acute Myocardial Infarction: A Meta-Analysis

The relationship between galectin-3 levels and fragmented QRS (fQRS) in patients with heart failure with reduced left ventricular ejection fraction

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the

Interleukin-6 inhibition of hERG underlies risk for acquired long QT in cardiac and systemic inflammation

Nonspecific electrocardiographic abnormality as a predictor of coronary heart disease: the Framingham Study

Simulation studies of the electrocardiogram. II. Ischemia and infarction

Sex differential in the relationship of electrocardiographic ST-T abnormalities to risk of coronary death: 11.5 year follow-up findings of the Chicago Heart Association Detection Project in Industry

Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan

ACE2: from vasopeptidase to SARS virus receptor

COVID-19 and the cardiovascular system

Out-of-Hospital Cardiac Arrest during the Covid-19 Outbreak in Italy

Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study

COVID-19, Arrhythmic Risk and Inflammation: Mind the Gap! Circulation

Data are given as mean ± SD. Data are given as mean ± SD.